首页 > 市场调查报告书 > 製药

妇科治疗

激素替代疗法市场：按疗法类型、给药途径、应用、分销渠道、地区 - 规模、份额、前景和机会分析，2022-2030

市场调查报告书

商品编码

1110223

激素替代疗法市场：按疗法类型、给药途径、应用、分销渠道、地区 - 规模、份额、前景和机会分析，2022-2030

Hormone Replacement Therapy Market, by Therapy Type, by Route of Administration, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年07月26日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3个工作天内

价格

简介目录

激素替代疗法 (HRT) 有助于在绝经期间或接近绝经期间平衡雌激素和孕激素水平。激素替代疗法 (HRT) 是一种缓解更年期症状的治疗方法。它取代了随着您接近更年期而下降的荷尔蒙。在更年期，雌激素水平下降。一些女性会出现不适症状，例如潮热和阴道干燥。 HRT（也称为激素疗法、更年期激素疗法和雌激素替代疗法）是针对更年期症状最有效的治疗方法。激素替代疗法包括缓解潮热和盗汗，良好的睡眠，缓解阴道干涩和瘙痒，缓解性交疼痛，预防骨质疏鬆引起的骨折，预防心脏病，预防痴呆。要有效。

市场动态

由于各种製造商用于激素替代疗法的仿製药增加，预计市场的数量和价值将增长。例如，梯瓦製药工业有限公司于 2017 年 8 月 18 日在美国.在市场上推出。溶液通过带有腋下涂药器的计量泵输送。此外，2022 年 4 月，製药公司 Lupin Limited 在美国市场推出了妊娠预防药物“Merzee 胶囊”。 Merzee（醋酸炔诺酮和炔雌醇胶囊，富马酸亚铁胶囊），1mg/20mcg，是 Allergan Pharmaceuticals 的 Teitula 胶囊的仿製药。印度药品製造商 Lupin 与专门从事复杂仿製药开发、製造和采购的 Slaybak Pharma LLC 签订了独家许可、营销和分销协议，并已在美国市场推出。

本研究的主要特点

本报告对全球激素替代疗法市场进行了深入分析，提供了以 2021 年为基准年的预测期（2022-2030 年）的市场规模和復合年增长率 (CAGR%)。
解释不同细分市场的潜在收入机会，并描述该市场具有吸引力的投资建议矩阵。
该研究还提供了有关市场驱动因素、抑制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
根据公司亮点、产品组合、关键亮点、财务业绩和战略等参数，对全球激素替代疗法市场的主要参与者进行简介。
本研究涵盖的主要公司包括诺华公司、雅培公司、迈兰公司、默克公司、拜耳公司、辉瑞公司、诺和诺德 A/S、QuatRx 製药公司、梯瓦製药工业有限公司、安进公司。和礼来公司
本报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。奖品
全球激素替代疗法市场报告针对该行业的各种利益相关者，包括投资者和供应商、产品製造商、分销商、新进入者和财务分析师。牙齿，
通过分析全球激素替代疗法市场中使用的各种策略矩阵，可以轻鬆做出决策。

内容

第 1 章目的和先决条件

调查目的
先决条件
缩写说明

第2章市场展望

举报内容
- 市场定义和范围
执行摘要
- 市场快照：按治疗类型
- 按管理途径划分的市场概况
- 市场快照：按应用
- 市场快照：按分销渠道
- 市场概况：按地区划分
连贯的机会图 (COM)

第 3 章市场动态、法规和趋势分析

市场动态
- 驱动程序
- 约束因素
- 市场机会
影响分析
市场趋势
近期趋势
收购和合作方案
技术概述
监管场景
价格分析
PEST 分析

第 4 章全球激素替代疗法市场 - 冠状病毒 (COVID-19) 大流行的影响

整体影响
政府举措
COVID-19 对市场的影响

第 5 章全球激素替代疗法市场，按疗法类型，2017-2030 年

雌激素替代疗法
人类生长激素 (HGH) 替代疗法
甲状腺替代疗法
雄性激素替代疗法

第 6 章全球激素替代疗法市场：按给药途径，2017-2030 年

口语
肠胃外给药
其他

第 7 章全球激素替代疗法市场：按应用分列，2017-2030 年

甲状腺功能减退
男性性腺机能减退
生长激素缺乏症
更年期
其他

第 8 章全球激素替代疗法市场：2017-2030 年分销渠道

医院药房
零售药房
在线药店

第 9 章按地区分列的全球激素替代疗法市场，2017-2030

北美
美国
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地区
欧洲
英国
德国
意大利
法国
西班牙
俄罗斯
其他欧洲
亚太地区
中国
印度
日本
东盟
澳大利亚
韩国
其他亚太地区
中东
海合会
以色列
其他中东地区
非洲
北非
中非
南非

第 10 章竞争格局

热图分析
公司简介
- Novartis AG
- Abbott Laboratories
- Mylan NV
- Merck KgaA
- Bayer AG
- Pfizer Inc.
- Novo Nordisk A/S
- QuatRx Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Amgen, Inc.
- Eli Lilly and Company

第11章章节

参考文献
调查手法

简介目录

Product Code: CMI2079

Hormone replacement therapy (HRT) can help balance estrogen and progesterone levels during or near menopause. Hormone replacement therapy (HRT) is a treatment to relieve symptoms of menopause. It replaces hormones that are at a lower level as approach the menopause. During menopause, estrogen levels fall. Some women get uncomfortable symptoms such as hot flashes and vaginal dryness. HRT (also known as hormone therapy, menopausal hormone therapy, and estrogen replacement therapy) is the most effective treatment for menopause symptoms. The benefits of hormone replacement therapy are that it relieves hot flashes and night sweats, helps sleep better, eases vaginal dryness and itching, makes sexual intercourse less painful, helps prevent fractures caused by osteoporosis (thinning bones), make some women less likely to have heart disease, and lowers chances of dementia.

Market Dynamics

Rising number of generic versions of hormone replacement therapies by various manufacturers would drive growth of market in terms of volume and value. For instance, Teva Pharmaceutical Industries Ltd. launched the generic Axiron1 (testosterone) topical solution CIII, 30 mg/1.5 mL, in the U.S. on August 18, 2017 to treat adult males who have low or no testosterone due to certain medical conditions. This solution was supplied in a metered dose pump with an underarm applicator. Moreover, in April 2022, Lupin Limited, a pharmaceutical company, launched Merzee capsules, a medication used to prevent pregnancy, in the U.S. market. Merzee (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1 mg/20 mcg is a generic equivalent of Allergan Pharmaceuticals' Taytulla capsules. The Lupin Limited, India-based drug maker had launched the product in the U.S. market under exclusive license, marketing and distribution agreement with Slayback Pharma LLC, a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products from Lupin Ltd.

Key features of the study:

This report provides an in-depth analysis of the global hormone replacement therapy market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global hormone replacement therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis AG, Abbott Laboratories, Mylan NV, Merck KgaA, Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Amgen, Inc., and Eli Lilly and Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global hormone replacement therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hormone replacement therapy market

Detailed Segmentation:

Global Hormone Replacement Therapy Market, By Therapy Type:
- Estrogen Replacement Therapy
- Human Growth Hormone (HGH) Replacement Therapy
- Thyroid Replacement Therapy
- Testosterone Replacement Therapy
Global Hormone Replacement Therapy Market, By Route Of Administration:
- Oral
- Parenteral
- Others
Global Hormone Replacement Therapy Market, By Application:
- Hypothyroidism
- Male Hypogonadism
- Growth Hormone Deficiency
- Menopause
- Others
Global Hormone Replacement Therapy Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Hormone Replacement Therapy Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Region/Country
- South Africa
- Central Africa
- North Africa
Company Profiles
- Novartis AG*
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Abbott Laboratories
- Mylan NV
- Merck KgaA
- Bayer AG
- Pfizer Inc.
- Novo Nordisk A/S
- QuatRx Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Amgen, Inc.
- Eli Lilly and Company

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Route Of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis

4. Global Hormone Replacement Therapy Market- Impact of Coronavirus (Covid-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Hormone Replacement Therapy Market, By Therapy Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Estrogen Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Human Growth Hormone (HGH) Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Thyroid Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Testosterone Replacement Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Hormone Replacement Therapy Market, By Route Of Administration, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Hormone Replacement Therapy Market, By Application, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hypothyroidism
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Male Hypogonadism
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Growth Hormone Deficiency
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Menopause
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Hormone Replacement Therapy Market, By Distribution Channel, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Hormone Replacement Therapy Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa